Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

Valérie Lallemand-Breitenbach1, Marion Jeanne, Shirine Benhenda

  • 1Université de Paris 7/CNRS UMR 7151, Equipe Labellisée N11 Ligue Nationale Contre le Cancer, Hôpital St. Louis, 1, Av. C. Vellefaux 75475 Paris CEDEX 10 France.

Nature Cell Biology
|April 15, 2008
PubMed

Insights

Arsenic trioxide triggers PML degradation in acute promyelocytic leukaemia (APL) by initiating SUMOylation-dependent polyubiquitination. This PML-RARA oncogene catabolism is crucial for arsenic

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Arsenic trioxide is a key treatment for acute promyelocytic leukaemia (APL), inducing leukaemic cell differentiation and remission.
  • The mechanism involves degradation of the PML-RARA oncogene, but the specific degradation pathway and role of catabolism remain unclear.
  • SUMOylation of the PML moiety was previously suggested but not fully elucidated.

Purpose of the Study:

  • To elucidate the degradation pathway of the PML-RARA fusion protein induced by arsenic trioxide in APL.
  • To investigate the role of PML-RARalpha catabolism in the therapeutic response to arsenic trioxide.
  • To identify the specific E3 ubiquitin ligase involved in arsenic-induced PML degradation.

Main Methods:

  • Demonstration of arsenic-induced PML SUMOylation triggering Lys 48-linked polyubiquitination and proteasome degradation.
  • Recruitment analysis of RNF4, ubiquitin, and proteasomes to PML nuclear bodies upon arsenic exposure.
  • Assessment of arsenic-induced differentiation using non-degradable PML-RARalpha SUMOylation mutants and dominant-negative RNF4 in APL cells.

Main Results:

  • Arsenic-induced PML SUMOylation directly leads to its polyubiquitination and proteasomal degradation.
  • RNF4, a SUMO-dependent E3 ubiquitin ligase, is recruited to PML nuclear bodies along with ubiquitin and proteasomes.
  • Impaired arsenic-induced differentiation in cells with non-degradable PML-RARalpha or dominant-negative RNF4 confirms the critical role of catabolism.

Conclusions:

  • PML is identified as the first protein degraded via SUMO-dependent polyubiquitination, mediated by RNF4.
  • PML-RARalpha catabolism is essential for the therapeutic efficacy of arsenic trioxide in APL.
  • PML nuclear bodies may serve as platforms integrating SUMOylation, ubiquitination, and degradation pathways.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.